In conclusion, Klf5 is efficiently downregulated in imatinib-resistant p190-BCR-ABL B-ALL leukemic cells and it acts as a negative regulator of the anti-oxidant glutathione. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.